Ariavax
2000
FOUNDED
OOB
STATUS
Out of Business
LATEST DEAL TYPE
Description
Developer of vaccines that are designed to selectively and specifically generate effective antibody-inducing immune responses. The company's vaccines are based on its proprietary peptide chemistry technology, providing users with vaccines that are safer, more stable and less expensive than current vaccines.
Website
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Primary Office
- 708 Quince Orchard Road
- Gaithersburg, MD 20878
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ariavax’s full profile, request a free trial.
Ariavax Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Jun-2013 | Completed | Out of Business | |||
| 3. Grant | 01-Feb-2009 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 01-May-2005 | $218K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Startup |